Treatment of Adriamycin, a type of chemotherapy, may be linked with breast cancer in Hodgkin lymphoma survivors, a study showed. Survivors of Hodgkin lymphoma who have received Adriamycin (doxorubicin ...
After the publication of the 10-year survival data from Milan on the adjuvant use of the block sequential regimen consisting of four cycles of adriamycin followed by eight cycles of intravenous CMF, ...
Doxorubicin (Adriamycin (50 mg)) is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.It works by killing cancer cells. The information provided on this page is ...
Effect of circulating tumor cells distribution in treatment naive and treated patients with advance stage breast cancer on disease burden. Amelioration of acute radiation dermatitis in patients with ...
Predictive value of circulating VEGF in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma treated with cetuximab in combination with cisplatin and docetaxel (Italian ...
This trial looked at a combination of bortezomib, adriamycin and dexamethasone (PAD) for myeloma. It was for people who had not had any other treatment for their myeloma. The trial was open for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results